Genomic Health to develop cancer biomarkers for OncoMed
This article was originally published in Scrip
Executive Summary
Genomic Health and OncoMed Pharmaceuticals, both based in Redwood City, California, entered into a strategic alliance to identify biomarkers for clinical development of OncoMed's novel antibody cancer therapeutics.